chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe pain in left arm, unable to raise arm or lift anything. Sudden, profuse diarrhea unlike anything I've ever experienced (about 6 hours after shot).
Bilateral swelling of joints of lt wrist, rt ankle, & lt knee; 27JUL91 rash-erythematous, petechial to hemorrhagic in appearance, swelling, tenderness; Seen @ ER; dx HS purpura; hospitalized 1AUG-3AUG purpuric rash, arthralgia, n,v, dehdrat
Patient came in today and mentioned that his right arm felt sore and warm after receiving the Flu-HD vaccine on the 17th. He also reported that a few days later that arm felt even more sore at the joint especially when he tried to raise his arm.
Itching and tingling of mouth; Itching and tingling of mouth; This is a spontaneous report from a contactable nurse, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: unknown) via an unspecified route of administration in the left arm on 18Mar2021 at 12:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any concomitant medications. The patient had allergies to (unspecified) medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021 at 13:00, about 1 hour after the vaccination, the patient experienced itching mouth and tingling mouth. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with BENADRYL. The clinical outcomes of the events itching mouth and tingling mouth were resolved on unknown date.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Information has been received from a public health registered nurse concerning two children who on unspecified dates were vaccinated with varicella vaccine. There was no concomitant medications reported. The public health nurse was informed by a school nurse in her area that after vaccination with varicella vaccine two children in the school had "a chicken pox rash." It was unknown if the children sought medical attention. No further details were available. Additional info has been requested.
Patient reported an injection-site reaction, consisting of swelling, redness, and itching around the injection site. The site was also painful to touch.
COVID-19 Asymptomatic; COVID-19 Asymptomatic; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36-year-old male patient received BNT162b2 (BNT162B2), on 02Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 35 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Bowel issues" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), ASYMPTOMATIC COVID-19 (medically significant) all with onset 2022, outcome "recovering" and all described as "COVID-19 Asymptomatic". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (17Sep2022) Positive, notes: after testing negative on Day 11; (Sep2022) Negative, notes: Day 11; (2022) Positive, notes: first positive test. Therapeutic measures were taken as a result of drug ineffective, asymptomatic covid-19.  Additional information: No known allergies. Patient received paxlovid as COVID 19 treatment from 06Sep2022 to 10Sep2022. Asymptomatic. Tested positive (17Sep2022) after testing negative on Day 11 after first positive test. He was recovering. Treatment received included Zyrtec.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PATIENT HAS HAD LARYNGITIS AND MILD SHORTNESS OF BREATH WITH LIMITATIONS ON EXCERCISE THAT HE IS ACCUSTOMED TO. WALKING 2 MILES SEVERAL TIMES WEEKLY.  HE IS FOLLOWING UP WITH HIS DOCTORS.
He received the H1N1 shot on Monday 9-21-09. He called me last night to tell me that he had a severe stomach ache all day today - tried to eat and about 11:00 pm ended up throwing up and was very concerned because there was a significant amount of blood in the matter he threw up.  He went to the watch and they took him to the emergency room where they gave him one day of sick in quarters.  I don't know what the diagnosis was, but usually you are pretty ill to get SIQ. My son never has stomach aches.  Rarely throws up. Never has thrown up blood.   He was not running a fever, but the whole event scared him enough that he asked me what he thought he should do because they don't like people to "cry" sick.   I told him to make them take him to the emergency room.
Rash on right flank and abdomen, painful, dxed with shingles.
For several days after the vaccination shots, patient felt acute shoulder pain that ran down the arm. Several months (less than a year) after the vaccine was administered, patient went the Emergency Room due to acute chest pain. it was later discovered that patient had a heart attack due to 99 percent blockage in the left anterior descending artery of the heart. A stent was placed and the patient was hospitalized for 2 days.
Severe generalized  pain, stomach pain,  chest pain with burning sensation during breathing.  Back pain and ear pain,    Start taking tylenol and ibuprofen,  feels better
I tested positive for Covid/SARS on 8/3/2021 after successfully completing both vaccinations on schedule.
Awoke with very sore arm at injection site.  Went to bathroom first, then kitchen to take Aleve.  Fainted before before I could take the Aleve.  Came to on floor, bleeding from 2cm laceration above right ear where I hit a cabinet (hard enough to break the door).  Uncertain of duration of unconsciousness.  Sat on floor until dizziness and cold, clammy sweat subsided.  Returned to bed and went back to sleep.  No other adverse events on awakening.  Went to urgent care clinic when it opened for the day for exam.  No skull fractures or signs of concussion.  Doctor did find TM erythematous of sinus tenderness.
No adverse event; Dose 1: 09/13/2021, dose 2:05/04/2022; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1: 09/13/2021, dose 2:05/04/2022) and NO ADVERSE EVENT (No adverse event) in an 80-year-old male patient who received mRNA-1273 (Spikevax) (batch nos. 004M21A and 014F21A) for COVID-19 prophylaxis.     It was unknown if the patient was diagnosed with or tested positive for COVID-19.    On 13-Sep-2021, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 dosage form. On 04-May-2022, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to .5 dosage form. On 04-May-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1: 09/13/2021, dose 2:05/04/2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1: 09/13/2021, dose 2:05/04/2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1: 09/13/2021, dose 2:05/04/2022).    No concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2023-721275 (Patient Link).
pt recvd vax 25OCT94 1130AM & 1PM pt c/o itching on neck & head then devel gen itching & rash that noc; seen morning 26OCT pt reports swelling of lips & tightness of throat;felt tongue swollen & fingers were swollen went to MD
Nausea, Loose Stools, Chills, Sweating, Body Aches.
One minute p/administration of vax, pt felt faint, was helped  to floor & lost consciousness; briefly regained consciousness then fainted again; Both assoc w/beats of generalized clonus; Also nauseated & emesis;
Headache, Fever, Diarrhea, fatigue, upper back stiffness Narrative:  Other Relevant History:
Information has been received from a physician, via company representative, concerning a patient who was vaccinated with a dose, 0.5ml, IM, of Gardasil (date not specified). Subsequently the patient "had a reaction to Gardasil." The patient sought unspecified medical attention. Additional information has been requested.
Smallpox vaccination given 2/11/03. PT developed temp of 100.7 p.m. at 2/11/03. PT complained of URI symptoms. Vaccination site checked - no redness, swelling or signs of infection.
vaccine drips down or leaks out of the syringe when injecting; good quantity of the first dose of the Gardasil vaccine drips down or leaks out of the syringe when injecting, should this dose be repeated; No additional information or AE/PQC reported; This spontaneous report was received from a consumer and refers to an adult patient of an unknown age and gender. No information regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medications was provided.  On an unknown date, the patient was vaccinated with a good quantity of the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (dose, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis.  The quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccine dripped down and leaked out of the syringe when injecting. The reported asked if the dose should be repeated. No additional information or event was reported.
Began about 3/8/22 with runny nose and slight itchy neck, worse on left side of neck but no visible redness or bumps.  By 3/11  whole body was itchy.  Using Allegra.  Evening clothes touching my neck in any way made things worse so I put Band-Aids across that left side of my neck so nothing could touch the skin.   Night of 3/16 a lot worse itchiness all over.  Got up in the middle of the night and took a warm bath hoping for some relief.   I put a turtleneck top on instead of a pajama top to try to lessen the itchiness.  Got very little sleep.  Not getting better so went to Urgent Care in the afternoon of 3/17/22.   Dr. said it was an allergic reaction to something and prescribed Triamcinolone Acetonide Cream.
Pt given Tdap 0.5 ml IM on May 22, 2008 at 1158AM by nurse - R deltoid IM.  Returned May 22, 2008 at 2030pm with c/o vomiting since noon - no other c/o.
Dizzy; "Wobbly on his feet." / needs to use a walker or cane; This case was reported by a consumer via call center representative and described the occurrence of dizziness in a 95-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th November 2020, the patient received the 2nd dose of Shingrix. On 20th November 2020, 1 days after receiving Shingrix, the patient experienced dizziness and unsteady gait. On an unknown date, the outcome of the dizziness and unsteady gait were not recovered/not resolved.   It was unknown if the reporter considered the dizziness and unsteady gait to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and feeling dizzy and wobbly on his feet needs to use a walker or cane to steady himself.  The events had not resolved at time of report. The reporter unable to remain on the phone and did not provide demographics or any other information for this AE.
Initial information received on 10-Dec-2018 regarding an unsolicited valid non-serious case received from a Nurse. This case involves an 18-years-old patient (age at the time of first vaccination was 13 years), (gender was not specified) who was vaccinated with a first dose and second doses of vaccine MENACTRA (lot number and expiry date was not reported) on 20-Aug-2014 and then again 30-Jun-2015 respectively. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It was an actual medication error due to extra dose administered. It was not reported if the patient experience any adverse events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
Started with chills at night, left arm hurt a lot. Today Sunday Still hurt but not too much. I start to fell very tired and cold, also sleep. I told my temperature around 12pm and it is at 100.1. Slightly have a headache. Also lost of  appetite .
This spontaneous case reported by a consumer, describes the occurrence of chest discomfort (chest tightness), tremor (shaking), chills, pyrexia (fever) and nausea in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 013L20A and 026L20A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported.  On Jan 2, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jan 30, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jan 31, 2021, patient experienced chest discomfort (chest tightness), tremor (shaking), chills and pyrexia (fever). On Jan 31, 2021 at 3:00 am, patient experienced chest pain (my son experienced chest pain and chest tightness). On an unknown date, patient experienced nausea. On Jan 31, 2021 at 5:00 am, chest pain (my son experienced chest pain and chest tightness) resolved. At the time of the report, chest discomfort (chest tightness), tremor (shaking), chills, pyrexia (fever) and nausea outcome: unknown. The reporter did not provide any causality assessments, concomitant medications or treatment information.
patient presented to the ED with a itchy rash on arms and back and eventually  became disseminated.  progressed within 24 hrs of being given the vaccine.    accompanied with fatigue and mild sore throat
Arm paresthesias (burning pain) with chills 1-2 hrs after shot. Progressed over 24 hrs to include arm, bronchial plexus and neck with decreased ROM began to improve after 48 hrs. Exam today shows mottled macular rash over arm and shoulders stop and at elbow with full RAS. Neck and arm but painful. Given rx of Allegra 180 Keflex 500 tid x 7 days. cont. Motrin.
Injection site soreness; Aches and tiredness starting about 24 hours after injection; Aches and tiredness starting about 24 hours after injection.; This is a spontaneous report from a contactable consumer (patient). A 41-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 25Mar2021 11:30 (Batch/Lot Number: EK5730) at the age of 41-years-old as single dose for covid-19 immunisation. The COVID-19 vaccine was administered at Workplace clinic. Patient was not pregnant. Medical history included High Blood Pressure, Hypoparathyroidism, allergies to Penicillin, Bleach. The patient concomitant medication included unspecified medication within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162B2 (lot number: EJ1685) at left arm on 04Mar2021 11:00 AM for covid-19 immunisation. The patient experienced injection site soreness, aches and tiredness starting about 24 hours after injection on 26Mar2021 11:00 AM. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovering.
This spontaneous report was received from a registered nurse refers to a pediatric patient of unknown age who on 11-JAN-2013, was vaccinated with a dose of ZOSTAVAX (dose, route and lot number not reported) rather than intended VARIVAX (Merck). No adverse effects were reported. Additional information has been requested.
1 of 2 pts who devel an inj site rxn following vax;pt's arm became red & swollen from site of inj to elbow;pt instructed to take ASA if sxs worsened;ASA was not taken;sxs lasted 1wk; pt recovered;
Tachycardia Narrative:  Employee went home for mild tachycardia (100bpm) at the time of this report.
Headache; This case was reported by a consumer via call center representative and described the occurrence of headache in an unspecified number of adult patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced headache. On an unknown date, the outcome of the headache was unknown.   It was unknown if the reporter considered the headache to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not provided. The age group of the patients was not reported, but selected as an adult as per vaccine indication. The reporter heard about that people on the younger side of 50-65 age seem to get the headaches. The reporter did not consent to follow up. This case had been linked to the case US2019AMR180771, reported by same reporter.
This case was reported by a pharmacist via call center representative and described the occurrence of extensive swelling of vaccinated limb in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a week after receiving SHINGRIX, the patient experienced extensive swelling of vaccinated limb, injection site redness, injection site itching and injection site induration. On an unknown date, the outcome of the extensive swelling of vaccinated limb, injection site redness, injection site itching and injection site induration were unknown. It was unknown if the reporter considered the extensive swelling of vaccinated limb, injection site redness, injection site itching and injection site induration to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The pharmacist reported that the patient received SHINGRIX and during that week had a reaction of red arm and swollen, itching, hard from injection site down to where a short sleeve would end. The pharmacist asked if any information was available and gathered the patient information.
0845: generalized weakness, headache, and all over tingling sensation (hard to put into words,)  0900: noticed difficulty in swallowing and swelling bilateral side of the neck from top of the ear to bottom of neck.  Throat felt slightly tight, not all he way around the esophagus; pressure from the sides. 0902 notified the desk that I was having a reaction 0902 was brought back into triage and vital signs were taken: heart rate in the 70's, blood pressure within normal parameters, oxygen was 100% on room air and respirations were within the normal parameters. The 2 nurses did an focused assessment, no hives or rash, swelling present face ( eye, lips, or face) Just swollen in the neck area. 0905  25mg  Benadryl  po -liquid was given 0915 vital signs were retaken and vital signs were in the same range as previously mentioned.   The nurse asked if  I could stay to monitor signs and symptoms.  0930: I felt like the swelling was going down slightly. 0955: Was rechecked by the nurses and was released. Was told to monitor symptoms at home and go to the er if anything should change. **times might slightly vary per what is stated, tried the best to my ability to recall the exact time line
Body aches including bones and muscles. Body aches including bones and muscles. Fever (high temperature), blurred vision, headache. Extreme exhaustion. Nausea, Chest pain, high blood pressure. 12/19/06-records received and reviewed. krk DX:Depression Axix I: Anxiety disorder NOS MDD-moderate II None III Discogenic disease of lumbar spine and cervical spine. Chronice back pain, cervical spine and lumbar spine. Right knee pain r/o meniscus tear. IV primary group, marital separation. Military experience-military trauma and legal issues related. V GAF=50 Surgery: Laminectomy 4/2006 Rt knee meniscus 1998 and 2004.
The next day after the shot, I started to feel light headed, dizzy and I also started getting a headache too. This happened around 10:00 AM.
Three hours post vax temperature started going up. At 9:00 pm she took infant to hospital for temp up to 104.6F. She was treated at ER with Motrin to reduce temp.
Narrative:  02/09 COVID vaccine dose #1, pt c/o lightheadedness and found to be tacchycardia immediately following, monitored x 30 minutes and released; returned shortly after w/ c/o continued dizziness, nausea; given PO fluids, food; symptoms resolved
pt has shakes, chills, dizziness; no LOC post plaque vax; seen by MD;
Received the booster vaccine, dose number three. Within 24 hours of receiving the booster, I began a menstrual cycle a full 2 weeks ahead of its normal time to begin.
Generalized decline in status: increased lethargy, increased weakness, decreased oral intake of food and liquids, alert but decreased socialization all of which have progressively gotten worse but was first noted the early morning of 6/18/21 which was about 12 hours after administration of the vaccine. Currently, resident is not exhibiting s/sx of generalized pain. Zoloft was d/c'd on 6/25 to see if the start of this medication induced residents symptoms. Since d/c of medication, residents status continues to decline with only new item in regimen being the second administration of the MODERNA vaccine.
Instead of receiving the pediatric dose, the patient received 0.2ml of the adult Pfizer COVID-19 vaccine, equivalent to 20mcg instead the 10mcg he should have received for his age.
Pt reported he went to ED for cellulitis after receiving his first Jyennos vaccination via SQ route.
Woke up with severe chills around 3:45 AM the morning after my vaccine. Temp was low grade at first but then climbed, max was 102.2°F. All over body aches, no appetite, weakness, fatigue, headache, nasal congestion, burning eyes, ataxia, lightheadedness. Took my AM meds including hydrocodone-APAP which caused the fever to break but stayed low grade until the following afternoon around 2 PM. Helped with the body aches somewhat as well. Appetite started to return this morning, 3 days after the vaccine but the fatigue, weakness, muscular pain and a general unwell feeling continues.